(RTTNews) - Biotechnology company Moderna Inc. (MRNA) Tuesday said it has reached a deal with Canadian government to build a state-of-the-art messenger RNA (mRNA) vaccine manufacturing facility in Canada including access to Moderna's mRNA development engine.
The goals of this MoU are to build the foundation to support Canada with direct access to rapid pandemic response capabilities and to provide access to Moderna's vaccines in development for respiratory viruses.
"I would like to thank the Government of Canada for the partnership they have built with us and for their faith in our data, science and early confidence in our mRNA platform in addressing the COVID-19 pandemic. We recently announced data from the final analysis of the Phase 3 COVE study demonstrating that vaccination with the Moderna COVID-19 vaccine showed 93% efficacy, with this efficacy remaining durable six months after administration of the second dose," said Stéphane Bancel, Chief Executive Officer of Moderna.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
